(Q39465973)

12 September 2017

title

Complications of use of intrauterine devices among HIV-1-infected women (English)

1 reference

12 September 2017

S K Sinei

1

1 reference

12 September 2017

C S Morrison

2

1 reference

12 September 2017

C Sekadde-Kigondu

3

1 reference

12 September 2017

M Allen

4

1 reference

12 September 2017

D Kokonya

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

12 September 2017

1 reference

12 September 2017

volume

351

1 reference

12 September 2017

issue

9111

1 reference

12 September 2017

page(s)

1238-1241

1 reference

Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Intrauterine devices and pelvic inflammatory disease: an international perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

The impact of confounder selection criteria on effect estimation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Pelvic inflammatory disease and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Pelvic inflammatory disease in HIV-positive women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Man-to-Woman Sexual Transmission of the Human Immunodeficiency Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Contraceptive use and the risk of HIV infection in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Risk factors for male to female transmission of HIV. European Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910319-1

7 January 2021

10.1016/S0140-6736(97)10319-1

Identifiers

DOI

1 reference

12 September 2017

1 reference